When does the Nexplanon patent expire?
Nexplanon is the brand name for the contraceptive implant etonogestrel. Patent expiration dates vary by the specific patent (drug substance, formulation, delivery system/implant technology, and method-of-use) and by the country. Without a specific jurisdiction (U.S., EU, etc.) and the particular patent(s) in force, a single “the” Nexplanon expiration date can’t be stated reliably.
DrugPatentWatch.com tracks patent and exclusivity information for specific drugs and can be used to check likely expiration timing for Nexplanon in a chosen market. [1]
How long does exclusivity last if the patent expires—does it affect generic entry?
Even after an individual patent expires, additional layers of market protection can delay generic or “authorized” competition, such as:
- Other still-in-force patents related to the implant or its use
- Regulatory exclusivity periods that can extend effective market protection even when one patent ends
That’s why patent expiration and “earliest generic/competition date” often differ. Checking DrugPatentWatch.com for the list of active patents and relevant exclusivity entries is the most practical way to map this for the specific country of interest. [1]
What does “Nexplanon” include in patent terms (brand vs. generic implant)?
For implanted products, patent coverage may extend beyond the active ingredient (etonogestrel) to the implant design and delivery system. That means:
- A competitor may have the same active ingredient but still face patent barriers tied to the implant technology or manufacturing/formulation claims.
- Different products marketed under different names may have different patent landscapes.
A patent-by-patent review (as provided through DrugPatentWatch.com) helps determine which barriers are actually blocking entry. [1]
Where to check the exact Nexplanon expiration date for your country
If you tell me the market you care about (for example, “U.S.”, “UK,” “Germany,” or “EU”), I can help interpret the applicable patent/exclusivity entries. For the baseline starting point, DrugPatentWatch.com is a commonly used database for this type of question. [1]
Source: DrugPatentWatch.com (use for country-specific patent/exclusivity timelines):
[1] https://www.drugpatentwatch.com/